ARTICLE | Financial News
Galmed sets IPO range
March 4, 2014 1:58 AM UTC
Lipid and liver disease company Galmed Pharmaceuticals Ltd. (Tel Aviv, Israel) amended its IPO on NASDAQ and said it plans to sell 2.4 million shares at $12-$14. At the $13 mid-point, the company woul...